MRC [Medical Research Council]

MRC [Medical Research Council]

The Medical Research Council has been at the forefront of scientific discovery to improve human health. Founded in 1913 to tackle tuberculosis, the MRC now invests taxpayers’ money in some of the best medical research in the world across every area of health.

Telephone: +44 (0)1223 268 101
Address: MRC Centre, MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge
Postcode: CB2 0QH
Country: United Kingdom
Website: http://www.mrc-centre.cam.ac.uk
Membership type:Corporate 51+ (£1,000+VAT pa)

Twenty-nine MRC-funded researchers have won Nobel prizes in a wide range of disciplines, and MRC scientists have been behind such diverse discoveries as vitamins, the structure of DNA and the link between smoking and cancer, as well as achievements such as pioneering the use of randomised controlled trials, the invention of MRI scanning, and the development of a group of antibodies used in the making of some of the most successful drugs ever developed.   Today, MRC-funded scientists tackle some of the greatest health problems facing humanity in the 21st century, from the rising tide of chronic diseases associated with ageing to the threats posed by rapidly mutating micro-organisms. www.mrc.ac.uk

Over £100m is invested annually in MRC research establishments in Cambridge, including funding for research in universities via grant programmes and through specialist MRC Centres.  The MRC Cancer Unit, the MRC Epidemiology Unit and the MRC Metabolic Diseases Unit are all based at the University of Cambridge.  The MRC has four other units in Cambridge: the MRC Biostatistics Unit, the MRC Cognition and Brain Sciences Unit, MRC Human Nutrition Research and the MRC Mitochondrial Diseases Unit.   In addition, the MRC currently supports around 100 external studentships in Cambridge.

The MRC Laboratory of Molecular Biology (LMB) is a flagship of the Cambridge Biomedical Campus and continues as a world-class institute for basic science, employing around 700 MRC staff.

Among the key strategic areas are: Neurosciences, including the use of brain imaging; cancer, including prevention and novel therapeutic approaches;  diabetes, obesity, and nutrition, as part of broader strategic efforts in Cambridge; studies of the biology of the mitochondria and relevance to disease and a major interest in biostatistics.

MRC Mitochondrial Biology Unit: www.mrc-mbu.cam.ac.uk

MRC Laboratory of Molecular Biology (LMB): www2.mrc-lmb.cam.ac.uk

MRC Human Nutrition Research: www.mrc-hnr.cam.ac.uk

MRC Cognition and Brain Sciences Unit: www.mrc-cbu.cam.ac.uk

MRC Biostatistics Unit: www.mrc-bsu.cam.ac.uk

MRC Metabolic Diseases Unit at the University of Cambridge: www.mrc-cord.org

MRC Cancer Unit at the University of Cambridge: www.mrc-cu.cam.ac.uk

MRC Epidemiology Unit at the University of Cambridge: www.mrc-epid.cam.ac.uk

nanopore sequencing

Decades of discovery set to revolutionise healthcare

It can be argued that the development of any successful innovation that transforms healthcare would not be possible without the knowledge derived from decades of discovery science preceding it.

2 November 2018Read in full

Professor Sir Gregory Winter

MRC scientist wins 2018 Nobel Prize in Chemistry

The MRC and the Cambridge Network community are delighted to congratulate Professor Sir Gregory Winter, a former Deputy Director of the MRC Laboratory of Molecular Biology, Cambridge, on being awarded a share of the Nobel Prize in Chemistry for his work on the phage display of peptides and antibodies.

4 October 2018Read in full

adding a piece of the jigsaw

Discovery could explain failed clinical trials for Alzheimer’s and provide a solution

MRC-funded scientists have discovered a vicious feedback loop underlying brain degeneration in Alzheimer’s disease, which may explain why so many drug trials have failed.

21 September 2018Read in full

New drugs could reduce risk of heart disease

New drugs could reduce risk of heart disease and diabetes when added to statins

New drugs that lower levels of triglycerides (a type of fat) in blood could further reduce the risk of heart attack when added to statins. These new drugs, which are in various stages of development, could also reduce blood glucose levels and the risk of diabetes, according to a new genetic study from the Medical Research Council Epidemiology Unit at the University of Cambridge.

20 September 2018Read in full

blood pressure genetics

Study of one million people leads to major advance in blood pressure genetics

Over 500 new gene regions that influence people’s blood pressure have been discovered in the largest global genetic study of blood pressure to date.

18 September 2018Read in full

Max Perutz Science Writing Award graphic

2018 Max Perutz Science Writing Award shortlist announced

Ten outstanding articles have been shortlisted for this year’s Max Perutz Science Writing Award, the MRC’s annual writing competition.

12 September 2018Read in full

Cutting-edge microscope

Cutting-edge microscope revealed at opening of new £5m structural biology centre

The Medical Research Council-University of Glasgow Centre for Virus Research (CVR) opened an innovative new structural biology centre yesterday (Tuesday), home to a cutting-edge JEOL CryoARM 300, the first cryo-electron microscope of this model in the United Kingdom, which will be used to image biological molecules at near atomic level.

12 September 2018Read in full

Investment in new mental health research networks

£8 million investment in new mental health research networks

Eight new networks designed to broaden mental health research have been announced by UK Research and Innovation (UKRI) today.

6 September 2018Read in full

stem cell-derived liver cells (orange)/H Rashidi 2018

Liver tissue implants made from stem cells show promising support of liver function

Stem cells transformed into 3D human liver tissue by scientists from the Medical Research Council (MRC) Centre for Regenerative Medicine at the University of Edinburgh show promising support of liver function when implanted into mice with a liver disease.

30 August 2018Read in full

MRC_Chemical shows promise

Chemical shows promise at killing glioblastoma cells in mouse studies

Scientists have identified a synthetic chemical, named KHS101, which causes the death of aggressive brain tumour cells from patients in laboratory tests.

17 August 2018Read in full

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7